Publications and Presentations Database
Disclosing the disclosure: factors associated with communicating the results of genetic susceptibility testing for Alzheimer's disease.
Journal of health communication. 14(8), 768-84. Abstract
(2009).
The role of disease perceptions and results sharing in psychological adaptation after genetic susceptibility testing: the REVEAL Study.
European journal of human genetics : EJHG. 18(12), 1296-301. Abstract
(2010).
Factors affecting recall of different types of personal genetic information about Alzheimer's disease risk: the REVEAL study..
Public health genomics. 18(2), 78-86. Abstract
(2015).
Comparing test-specific distress of susceptibility versus deterministic genetic testing for Alzheimer's disease.
Alzheimer's & Dementia : the journal of the Alzheimer's Association. 4(6), 406-13. Abstract
(2008).
A randomized controlled trial of disclosing genetic risk information for Alzheimer disease via telephone..
Genetics in medicine : official journal of the American College of Medical Genetics. 20(1), 132-41. Abstract
(2018).
A new scale measuring psychologic impact of genetic susceptibility testing for Alzheimer disease.
Alzheimer disease and associated disorders. 23(1), 50-6. Abstract
(2009).
Perceptions of familial risk in those seeking a genetic risk assessment for Alzheimer's disease.
Journal of genetic counseling. 18(2), 130-6. Abstract
(2009).
Effectiveness of a condensed protocol for disclosing APOE genotype and providing risk education for Alzheimer disease.
Genetics in medicine : official journal of the American College of Medical Genetics. 14(8), 742-8. Abstract
(2012).
Effect of Alzheimer disease genetic risk disclosure on dietary supplement use.
The American journal of clinical nutrition. 91(5), 1402-7. Abstract
(2010).